Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Docetaxel in Unresectable Leiomyosarcoma
NCT00004066Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Jun 1999
- Primary completion
- Oct 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in leiomyosarcoma (LMS), soft tissue sarcoma (STS), sponsored by Memorial Sloan Kettering Cancer Center. Started Jun 1999; status: completed.
02
Drugs
gemcitabinedocetaxel
03
Conditions
leiomyosarcoma (LMS)soft tissue sarcoma (STS)
Beyond the preview
Go deeper on NCT00004066.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004066.